Ireland
--:--IST
Recruiting Observational

Sensory Analysis and Cutaneous Mapping of Different Regional Anesthesia Techniques

NCT07445854 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-11-15
Last updated
2026-03-03

Condition(s) studied

Laparoscopic CholecystectomyPostoperative Pain ManagementRegional Anesthesia

Investigational drug(s) / intervention(s)

External Oblique Plane Block (EOPB)Serratus Intercostal Plane Block (SIPB)

External Oblique Plane Block (EOPB): Ultrasound-guided External Oblique Plane Block (EOPB) performed bilaterally using 0.25% bupivacaine (25 mL per side, total 50 mL) for postoperative analgesia in laparoscopic cholecystectomy.

Serratus Intercostal Plane Block (SIPB): Ultrasound-guided Serratus Intercostal Plane Block (SIPB) performed bilaterally using 0.25% bupivacaine (25 mL per side, total 50 mL) for postoperative analgesia in laparoscopic cholecystectomy.

Study summary

This prospective observational study aims to evaluate and compare the sensory block distribution and regression patterns of two regional anesthesia techniques - External Oblique Plane Block (EOPB) and Serratus Intercostal Plane Block (SIPB) - in patients undergoing laparoscopic cholecystectomy.

Thirty adult patients (ASA I-III, BMI ≤ 35 kg/m², ≥50 kg) scheduled for elective laparoscopic cholecystectomy procedures will be included, with 20 in each block group. Sensory block areas will be assessed using pinprick test, and dermatomal mapping will visualize the spread. The findings are expected to improve understanding of block behavior and guide multimodal analgesia strategies in laparoscopic cholecystectomy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Patients scheduled for elective laparoscopic cholecystectomy surgery and who have received a regional anesthesia technique for this purpose. * Aged between 18-75 years. * Belonging to ASA I-III group. * Having provided written informed consent. Exclusion Criteria: * Patients who refuse to participate. * Patients who did not receive a block. * Patients classified as ASA IV. * History of previous abdominal surgery (affecting the laparoscopic approach). * Patients with cognitive dysfunction or inability to cooperate. * Patients diagnosed with psychiatric disorders (schizophrenia, mania, depression, etc.). * Patients who have been using antipsychotic medication for more than 4 weeks.

Primary outcome measure(s)

  • Cutaneous Sensory Block Area of EOPB and SIPB — 30 minutes after block application
    The primary outcome is the dermatomal mapping of the cutaneous sensory block areas produced by the serratus intercostal plane block (SIPB) and external oblique plane block (EOPB), and the comparison of sensory block extent between the two techniques.

Trial sites (1)

FacilityCityRegionStatus
Samsun University, Samsun Training and Research Hospital Samsun Ilkadım Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07445854 on ClinicalTrials.gov ↗ ← All trials in Turkey